Comparing Surgery and Endoscopic Methods for Managing Malignant Gastric Outlet Obstruction in Pancreatic Cancer Patients
Led by IRCCS San Raffaele · Updated on 2026-01-15
250
Participants Needed
5
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
This research aims to compare the outcomes of three different procedures used to manage malignant Gastric Outlet Obstruction GOO caused by pancreatic cancer. GOO is a common complication in patients with biliopancreatic and gastroduodenal tumors, causing symptoms like vomiting, dehydration, and malnutrition, which can affect quality of life and chemotherapy tolerance. The study is observational, prospective, multicenter, and compares surgical gastroenterostomy, endoscopic stent placement, and EUS-guided gastroenterostomy in a uniform group of patients with recently diagnosed pancreatic adenocarcinoma.
The procedures being evaluated include surgical gastrojejunostomy, which creates a surgical connection between the stomach and jejunum endoscopic placement of self-expandable metal stents that open the obstructed area and EUS-guided gastrojejunostomy, which uses endoscopic ultrasound to place a metal stent creating a bypass between the stomach and a jejunal loop. Each participating center will perform the procedure that is standard in their practice without additional interventions beyond the studys assessments.
Participants will complete quality of life questionnaires at the start and during follow-up visits, but no extra procedures are required due to study participation. Researchers will monitor clinical success within 30 days, eating experience over 3 months, chemotherapy tolerance over 24 months, and nutritional status including body mass index and body composition over 6 months. Data collected during routine cancer care will be shared to evaluate the clinical impact, safety, and patient experience of each treatment method.
CONDITIONS
Brief Title
Management of Malignant Gastric Outlet Obstruction Between Surgery and Endoscopy
Research Team
G
Giuseppe Vanella, MD
L
Laura Apadula
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Confirmed diagnosis of pancreatic cancer by cytology or histology
Diagnosis made within the last 6 months and candidate for active treatment
Presence of gastric outlet obstruction caused by cancer confirmed by radiology or endoscopy
Candidate for one of the three procedures: endoscopic stenting, EUS-guided gastroenterostomy, or surgical gastroenterostomy
You will not qualify if you...
Under 18 years of age
Benign or uncertain gastrointestinal stenosis
Gastric outlet obstruction caused by cancers other than pancreatic cancer
Scheduled for or already had curative pancreatic surgery
Previous treatment for malignant gastric outlet obstruction
Undergoing additional biliary drainage procedures with risk of adverse events or affecting quality of life assessment
Presence of any percutaneous drainage devices
Unable or unwilling to provide informed consent
Contraindications to active palliation or need for venting gastrostomy or nasogastric tube alone
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Observational Management
Duration - Immediate procedure with follow-up assessments up to 6 months
Participants undergo one of the routine clinical procedures for malignant gastric outlet obstruction including endoscopic stenting, EUS-guided gastroenterostomy, or surgical gastroenterostomy as per standard care at their center. No additional treatments or interventions are provided by the study.
Visits aligned with routine clinical care and assessments over 6 months
Prospective Follow-up
Duration - Up to 24 months
Participants are followed prospectively to evaluate clinical outcomes including eating experience, chemotherapy tolerance, body mass index, body composition, and nutritional status.
Periodic visits for assessments up to 24 months
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Similar Trials
Safety and Effectiveness of a New 18F Labeled Fibroblast Activation Protein Probe for Early Tumor Detection
Including Lung, Pancreatic, Neuroendocrine, and Thyroid Cancers
Evaluating 18F-T2 PETCT Imaging for Detecting Tumors with High CAIX Levels in Adults
Phase 12a Study of 64Cu-LNTH-1363S PETCT Imaging in Patients with Sarcoma or Gastrointestinal Tract Cancer
Evaluating Safety, Dosage, and Imaging Correlation with FAP Expression
Exploratory Study of 68Ga-SorB PETCT Imaging to Diagnose Sortilin-Positive Solid Tumors
Open-label Phase 12 Trial Evaluating ODM-212 with Anti-cancer Therapies in Adults With Advanced Mesothelioma, Pancreatic Cancer, and NSCLC
Phase II Study of TQB2916 Injection Combined with Gemcitabine and Albumin-Paclitaxel as First Treatment for Metastatic Pancreatic Cancer
Study of AI for Early Cachexia Detection and Diet-Exercise Support in Pancreatic Cancer Patients
Randomized Study of IBI343 Plus Supportive Care Versus Placebo in Claudin 18.2-Positive Advanced Pancreatic Cancer After Prior Treatments
Evaluating Tislelizumab and SX-682 as Neoadjuvant Treatment for Surgically Removable Pancreatic Cancer
Comparing New and Traditional Preoperative Biliary Drainage Strategies for Patients with Resectable Pancreatic Head Cancer and Severe Obstructive Jaundice
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
EUS-guided gastroenterostomy versus duodenal stent placement and surgical gastrojejunostomy for the palliation of malignant gastric outlet obstruction: a systematic review and meta-analysis.
Mateus Bond Boghossian, Mateus Pereira Funari, Diogo Turiani Hourneaux De Moura...
Laparoscopic versus EUS-guided gastroenterostomy for gastric outlet obstruction: an international multicenter propensity score-matched comparison (with video).
Michiel Bronswijk, Giuseppe Vanella, Hannah van Malenstein...
Surgical gastrojejunostomy or endoscopic stent placement for the palliation of malignant gastric outlet obstruction (SUSTENT study): a multicenter randomized trial.
Suzanne M Jeurnink, Ewout W Steyerberg, Jeanin E van Hooft...